Unpacking Open Innovation: Absorptive Capacity, Exploratory and Exploitative Openness, and the Growth of Entrepreneurial Biopharmaceutical Firms
研究了美国和欧洲生物制药行业中小企业中吸收能力与外部关系对成长的影响，发现实现的吸收能力对成长至关重要，且探索性关系依赖研发连续性，利用性关系更依赖实现的吸收能力。
In this article, we explore the relationship between two key aspects of open innovation in small firms—absorptive capacity (ACAP) and external relationships—and their effects on growth in the U.S. and European biopharmaceutical sectors. Results from an international sample of 349 biopharmaceutical firms surveyed in the United States, United Kingdom, France, and Germany suggest that realized ACAP plays an important role in determining firms’ growth. In terms of the interaction between firms’ ACAP and external relationships, we find that engagement with exploratory relationships depends strongly on the continuity of R&D, while participation in exploitative relationships is more conditional on firms’ realized ACAP.